866-407-4380

Drug Rehab Virginia is here to help people with drug and/or alcohol abuse problems in Virginia. find treatment options. Due to our diverse networking system we can find a treatment option tailored to each individuals specific situation and needs. We are able to provide all phases of recovery included but not limited to, alcohol and/or drug intervention, drug and/or alcohol detox, in-patient treatment, out-patient treatment, short term treatment (30 days or less), long term treatment (90 days or longer).

We design personalized treatment programs to provide each abuser with the greatest chance of a successful recovery outcome. Our comprehensive networking system works hand in hand with all of the drug treatment centers in Virginia. At Drug Rehab Virginia we know that each individual is unique and are treated as such. Deciding upon a treatment option in Virginia, or anywhere can be a daunting task for any individual or family, we will guide you through each step of a comprehensive treatment plan for you or your loved one. We are determined in our mission, that every drug and/or alcohol abuser in Virginia. that has a desire to change their life will be given a chance to recover from their addiction and we are dedicated to ensuring that they are given the opportunity to do so. We realize that each individual in Virginia. is in a different financial situation and we will find treatment options for each individual regardless of their financial situation. No matter what your financial situation everyone will receive the treatment help they are looking for.          866-407-4380

Effective Solutions To Drug Addiction & Alcoholism Since 1971

OxyContin Lawsuits

In January, a Maine man who had filed a lawsuit against Purdue Pharma L.P. because he said he had become addicted to OxyContin withdrew his lawsuit. In December 2001, a North Carolina man who said he had gone through severe pain and other withdrawal symptoms after his physicians took him off OxyContin also withdrew his lawsuit.

In Febuary of 2002 several lawsuits were filed holding the makers of OxyContin responsible for people's addiction to the painkiller and a third complaint asking the court to restrict access to the drug. All were dismissed.

A plaintiffs group in Washington, D.C., has filed a $5.2 billion lawsuit against Purdue Pharma LP and Abbott Laboratories Inc. charging the drug companies with allegedly failing to warn patients the painkiller OxyContin is dangerously addictive.

The suit was filed by seven people who are former addicts or relatives of addicts, the suit charges the companies with aggressively marketing the drug without warning of the risks. The plaintiffs are also seeking class action status.

Stamford, Connecticut-based Purdue manufactures OxyContin, while Abbott co-markets the drug, a painkiller intended for use by terminal cancer patients and chronic pain sufferers. Allegations have surfaced that the drug has been linked to numerous deaths.

Purdue in May said it had met with officials from the federal Drug Enforcement Administration because of the agency's concerns about its illegal diversion and abuse. Purdue Pharma around the same time said it tried to reduce abuse of the prescription drug through several actions including halting distribution of the drug in 160 mg tablets, its highest-strength dosage.

According to the lawsuit, defendants ``made misrepresentations or failed to adequately and sufficiently warn individuals regarding the appropriate uses, risks and safety of OxyContin.'' It contends OxyContin's sales, which exceeded $1 billion in the United States in 2000, were the result of an ``aggressive marketing strategy'' to physicians, pharmacists and patients that, ``misrepresented the appropriate uses of OxyContin and failed to adequately disclose and discuss the safety issues and possible adverse effects of OxyContin use.''

Specifically, the suit quotes a May 2000 U.S. Food and Drug Administration warning letter to Purdue Pharma ordering the company to cease use of an advertisement for the drug that appeared in a medical journal. The suit quotes a section from the warning letter that suggests the advertisement inaccurately represents the drug as a first-line treatment for osteoarthritis. ``As a result of drug company defendants' inappropriate marketing of OxyContin, the drug has been inappropriately prescribed and used, unnecessarily putting people at risk of addiction to OxyContin,'' the suit alleges.

Drug Rehab Virginia Treatment Centers Referral Request First Name Phone (Home) Last Name Phone (Work) Email Address Phone (Cell) Seeking Help For choose Self Son Daughter Spouse Friend Family Other Age Group choose 12 to 17 18 to 25 26+ Main Drug Abused Choose Alcohol Cocaine Marijuana Meth Methadone Ecstasy PCP Speed Heroin LSD XTC Other Contact me by : Phone Home E-Mail Phone Work Phone Cell Any additional questions or comments To submit this form you must type the following number in the box below

Google Bookmarks   —  Share with a friend

Questions and Answers
Submit your Question :
	First Name : City : Security Code: